Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus

Vesicular stomatitis virus (VSV) has proven to be an effective vaccine vector for immunization against viral infection, but its potential to induce an immune response to a self-tumor antigen has not been investigated. We constructed a recombinant VSV expressing human dopachrome tautomerase (hDCT) an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bridle, Byram W, Boudreau, Jeanette E, Lichty, Brian D, Brunellière, Jérôme, Stephenson, Kyle, Koshy, Sandeep, Bramson, Jonathan L, Wan, Yonghong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2009
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835010/
https://ncbi.nlm.nih.gov/pubmed/19603003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.154
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi